Literature DB >> 31220265

Functional Hypogonadotropic Hypogonadism in Men: Underlying Neuroendocrine Mechanisms and Natural History.

Andrew A Dwyer1,2, Niraj R Chavan3, Hilana Lewkowitz-Shpuntoff2,4, Lacey Plummer2, Frances J Hayes2, Stephanie B Seminara2, William F Crowley2, Nelly Pitteloud5, Ravikumar Balasubramanian2.   

Abstract

CONTEXT: After completion of puberty a subset of men experience functional hypogonadotropic hypogonadism (FHH) secondary to excessive exercise or weight loss. This phenomenon is akin to hypothalamic amenorrhea (HA) in women, yet little is known about FHH in men.
OBJECTIVE: To investigate the neuroendocrine mechanisms, genetics, and natural history underlying FHH.
DESIGN: Retrospective study in an academic medical center. PARTICIPANTS: Healthy postpubertal men presenting with symptoms of hypogonadism in the setting of excessive exercise (>10 hours/week) or weight loss (>10% of body weight). Healthy age-matched men served as controls.
INTERVENTIONS: Clinical assessment, biochemical and neuroendocrine profiling, body composition, semen analysis, and genetic evaluation of genes known to cause isolated GnRH deficiency. MAIN OUTCOME MEASURES: Reproductive hormone levels, endogenous GnRH-induced LH pulse patterns, and rare genetic variants.
RESULTS: Ten men with FHH were compared with 18 age-matched controls. Patients had significantly lower body mass index, testosterone, LH, and mean LH pulse amplitudes yet normal LH pulse frequency, serum FSH, and sperm counts. Some patients exhibited nocturnal, sleep-entrained LH pulses characteristic of early puberty, and one FHH subject showed a completely apulsatile LH secretion. After decreased exercise and weight gain, five men with men had normalized serum testosterone levels, and symptoms resolved. Rare missense variants in NSMF (n = 1) and CHD7 (n = 1) were identified in two men with FHH.
CONCLUSIONS: FHH is a rare, reversible form of male GnRH deficiency. LH pulse patterns in male FHH are similar to those observed in women with HA. This study expands the spectrum of GnRH deficiency disorders in men.
Copyright © 2019 Endocrine Society.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31220265      PMCID: PMC6594303          DOI: 10.1210/jc.2018-02697

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  60 in total

1.  The serum inhibin B concentration and reference ranges in normozoospermia.

Authors:  Anne-Laure Barbotin; Caroline Ballot; Julien Sigala; Nassima Ramdane; Alain Duhamel; François Marcelli; Jean-Marc Rigot; Didier Dewailly; Pascal Pigny; Valerie Mitchell
Journal:  Eur J Endocrinol       Date:  2015-03-04       Impact factor: 6.664

2.  Intravenous administration of pulsatile gonadotropin-releasing hormone in hypothalamic amenorrhea: effects of dosage.

Authors:  N Santoro; M E Wierman; M Filicori; J Waldstreicher; W F Crowley
Journal:  J Clin Endocrinol Metab       Date:  1986-01       Impact factor: 5.958

3.  Neuroendocrine-gonadal axis in men: frequent sampling of LH, FSH, and testosterone.

Authors:  D I Spratt; L S O'Dea; D Schoenfeld; J Butler; P N Rao; W F Crowley
Journal:  Am J Physiol       Date:  1988-05

4.  Pulsatile intravenous gonadotropin-releasing hormone administration averts fasting-induced hypogonadotropism and hypoandrogenemia in healthy, normal weight men.

Authors:  J A Aloi; M Bergendahl; A Iranmanesh; J D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  1997-05       Impact factor: 5.958

5.  Reduced serum testosterone and prolactin levels in male distance runners.

Authors:  G D Wheeler; S R Wall; A N Belcastro; D C Cumming
Journal:  JAMA       Date:  1984-07-27       Impact factor: 56.272

6.  Effects of dietary protein content on IGF-I, testosterone, and body composition during 8 days of severe energy deficit and arduous physical activity.

Authors:  Joseph A Alemany; Bradley C Nindl; Mark D Kellogg; William J Tharion; Andrew J Young; Scott J Montain
Journal:  J Appl Physiol (1985)       Date:  2008-05-01

7.  Body weight and amenorrhea.

Authors:  A C Wentz
Journal:  Obstet Gynecol       Date:  1980-10       Impact factor: 7.661

8.  Reproductive function during fasting in men.

Authors:  A Klibanski; I Z Beitins; T Badger; R Little; J W McArthur
Journal:  J Clin Endocrinol Metab       Date:  1981-08       Impact factor: 5.958

9.  Trial of recombinant follicle-stimulating hormone pretreatment for GnRH-induced fertility in patients with congenital hypogonadotropic hypogonadism.

Authors:  Andrew A Dwyer; Gerasimos P Sykiotis; Frances J Hayes; Paul A Boepple; Hang Lee; Kevin R Loughlin; Martin Dym; Patrick M Sluss; William F Crowley; Nelly Pitteloud
Journal:  J Clin Endocrinol Metab       Date:  2013-09-13       Impact factor: 5.958

10.  A Complement for the WHO Laboratory Manual for the Examination and Processing of Human Semen (First Edition, 2010).

Authors:  Javier Sánchez-Álvarez; Ruth Cano-Corres; Xavier Fuentes-Arderiu
Journal:  EJIFCC       Date:  2012-10-12
View more
  4 in total

1.  Functional Hypogonadotropic Hypogonadism in Men: Underlying Neuroendocrine Mechanisms and Natural History.

Authors:  Andrew A Dwyer; Niraj R Chavan; Hilana Lewkowitz-Shpuntoff; Lacey Plummer; Frances J Hayes; Stephanie B Seminara; William F Crowley; Nelly Pitteloud; Ravikumar Balasubramanian
Journal:  J Clin Endocrinol Metab       Date:  2019-08-01       Impact factor: 5.958

Review 2.  Genetics of congenital hypogonadotropic hypogonadism: peculiarities and phenotype of an oligogenic disease.

Authors:  Richard Quinton; Marco Bonomi; Biagio Cangiano; Du Soon Swee
Journal:  Hum Genet       Date:  2020-03-21       Impact factor: 4.132

Review 3.  Hypogonadism in Exercising Males: Dysfunction or Adaptive-Regulatory Adjustment?

Authors:  Anthony C Hackney
Journal:  Front Endocrinol (Lausanne)       Date:  2020-01-31       Impact factor: 5.555

Review 4.  Recent Update on the Molecular Mechanisms of Gonadal Steroids Action in Adipose Tissue.

Authors:  Agata Wawrzkiewicz-Jałowiecka; Anna Lalik; Graça Soveral
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.